Clinical Trial Update: to Evaluate the Safety and Efficacy of Pitavastatin in Patients With IFG and Hyperlipidemia [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the safety and efficacy of pitavastatin in patients with impaired fasting glucose (prediabetes) and hyperlipidemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Prediabetes

Drugs mentioned

• Pitavastatin (Pitavastatin)

Snippet

Sponsor: JW Pharmaceutical | Conditions: HbA1c Level Associated With Lipid Compositions | Phase 4 | Status: COMPLETED